Blaabjerg M, Kristensen B W, Bonde C, Zimmer J
Anatomy and Neurobiology, Institute of Medical Biology, SDU-Odense University, Winsløwparken 21, DK-5000 C, Odense, Denmark. mblaabjerg@health..sdu.dk
Brain Res. 2001 Apr 13;898(1):91-104. doi: 10.1016/s0006-8993(01)02148-5.
The potential toxic effects of the metabotropic glutamate receptor agonist (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD) and its interactions with the N-methyl-D-aspartate (NMDA) receptor were studied in hippocampal brain slice cultures, using densitometric measurements of the cellular uptake of propidium iodide (PI) to quantify neuronal degeneration. Cultures exposed to ACPD, showed a concentration (2-5 mM) and time (1-4 days) dependent increase in PI uptake in CA1, CA3 and dentate subfields after 24 h and 48 h of exposure, with CA1 pyramidal cells being most sensitive. The neurodegeneration induced by 2 mM ACPD was completely abolished by addition of 10 microM of the NMDA receptor antagonist (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), while 20 microM of the 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainic acid receptor antagonist 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) had no effect. Co-exposing cultures to a subtoxic dose of 300 microM ACPD together with 10 microM NMDA, which at this dose is known to induce a fairly selective degeneration of CA1 pyramidal cells, significantly increased the PI uptake in both CA1 and CA3, compared to cultures exposed to 10 microM NMDA only. Adding the 300 microM ACPD as pretreatment for 30 min followed by a 30 min wash in normal medium before the ACPD/NMDA co-exposure, eliminated the potentiation of NMDA toxicity. The potentiation was also blocked by addition of 10 or 100 microM 2-methyl-6-(phenylethynyl)pyridine (MPEP) (mGluR5 antagonist) during the co-exposure, while a corresponding addition of 10 or 100 microM 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) (mGluR1 antagonist) had no effect. We conclude that, stimulation of metabotropic glutamate receptors with ACPD at concentrations of 2 mM or higher induces a distinct subfield-related and time and concentration dependent pattern of hippocampal degeneration, and that ACPD at subtoxic concentrations modulates NMDA-induced excitotoxicity through the mGluR5 receptor in a time dependent way.
在海马脑片培养物中研究了代谢型谷氨酸受体激动剂(1S,3R)-1-氨基环戊烷-1,3-二羧酸(ACPD)的潜在毒性作用及其与N-甲基-D-天冬氨酸(NMDA)受体的相互作用,使用碘化丙啶(PI)细胞摄取的光密度测量来量化神经元变性。暴露于ACPD的培养物在暴露24小时和48小时后,CA1、CA3和齿状亚区的PI摄取呈现浓度(2-5 mM)和时间(1-4天)依赖性增加,其中CA1锥体细胞最为敏感。添加10 microM的NMDA受体拮抗剂(5R,10S)-(+)-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺(MK-801)可完全消除2 mM ACPD诱导的神经变性,而20 microM的2-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)/海人酸受体拮抗剂2,3-二氧代-6-硝基-1,2,3,4-四氢苯并[f]喹喔啉-7-磺酰胺(NBQX)则没有效果。将培养物与300 microM ACPD的亚毒性剂量和10 microM NMDA共同暴露,已知该剂量的NMDA会诱导CA1锥体细胞发生相当选择性的变性,与仅暴露于10 microM NMDA的培养物相比,CA1和CA3中的PI摄取均显著增加。在ACPD/NMDA共同暴露前,先将300 microM ACPD预处理30分钟,然后在正常培养基中冲洗30分钟,可消除NMDA毒性的增强作用。在共同暴露期间添加10或100 microM 2-甲基-6-(苯乙炔基)吡啶(MPEP)(mGluR5拮抗剂)也可阻断这种增强作用,而相应添加10或100 microM 7-(羟基亚氨基)环丙烷[b]色烯-1a-羧酸乙酯(CPCCOEt)(mGluR1拮抗剂)则没有效果。我们得出结论,浓度为2 mM或更高的ACPD刺激代谢型谷氨酸受体会诱导海马变性呈现出明显的与亚区相关、时间和浓度依赖性的模式,并且亚毒性浓度的ACPD通过mGluR5受体以时间依赖性方式调节NMDA诱导的兴奋性毒性。